Cutler Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-23,200
Closed -$60K 5853
2022
Q2
$60K Sell
23,200
-1,700
-7% -$455K 0.01% 1818
2022
Q1
$143K Buy
24,900
+22,000
+759% +$5.22M 0.01% 1433
2021
Q4
$14K Buy
2,900
+2,700
+1,350% +$525K ﹤0.01% 3439
2021
Q3
$2K Hold
200
﹤0.01% 5121
2021
Q2
$1K Sell
200
-1,500
-88% -$314K ﹤0.01% 5463
2021
Q1
$36K Buy
1,700
+1,500
+750% +$329K ﹤0.01% 2693
2020
Q4
$2K Buy
+200
New +$45.9K ﹤0.01% 4263
2020
Q2
Sell
-5,000
Closed -$11K 5332
2020
Q1
$11K Buy
+5,000
New +$1.15M ﹤0.01% 2681
2019
Q4
Sell
-4,800
Closed -$52K 5095
2019
Q3
$52K Hold
4,800
0.01% 1518
2019
Q2
$52K Hold
4,800
0.01% 1518
2019
Q1
$67K Sell
4,800
-14,800
-76% -$2.73M 0.01% 1240
2018
Q4
$176K Buy
19,600
+4,300
+28% +$745K 0.02% 708
2018
Q3
$75K Sell
15,300
-2,500
-14% -$445K 0.01% 1362
2018
Q2
$124K Buy
17,800
+4,100
+30% +$636K 0.01% 1015
2018
Q1
$164K Sell
13,700
-35,900
-72% -$5.86M 0.02% 920
2017
Q4
$207K Sell
49,600
-29,800
-38% -$4.41M 0.01% 938
2017
Q3
$212K Buy
79,400
+21,000
+36% +$3.16M 0.01% 1134
2017
Q2
$238K Sell
58,400
-35,400
-38% -$4.26M 0.01% 1155
2017
Q1
$224K Sell
93,800
-7,100
-7% -$625K 0.01% 1104
2016
Q4
$974K Buy
100,900
+28,300
+39% +$2.3M 0.05% 422
2016
Q3
$647K Buy
72,600
+25,200
+53% +$2.38M 0.04% 493
2016
Q2
$297K Buy
47,400
+8,700
+22% +$752K 0.02% 866
2016
Q1
$424K Sell
38,700
-28,700
-43% -$2.6M 0.04% 598
2015
Q4
$235K Buy
+67,400
New +$8.14M 0.02% 1062

Other funds holding VRTX